Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HE95
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 110 | 114 | PF00656 | 0.633 |
CLV_NRD_NRD_1 | 129 | 131 | PF00675 | 0.472 |
CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.487 |
CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.520 |
CLV_PCSK_KEX2_1 | 128 | 130 | PF00082 | 0.437 |
CLV_PCSK_KEX2_1 | 151 | 153 | PF00082 | 0.358 |
CLV_PCSK_KEX2_1 | 213 | 215 | PF00082 | 0.493 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.520 |
CLV_PCSK_PC1ET2_1 | 128 | 130 | PF00082 | 0.437 |
CLV_PCSK_PC1ET2_1 | 151 | 153 | PF00082 | 0.358 |
CLV_PCSK_PC1ET2_1 | 213 | 215 | PF00082 | 0.493 |
CLV_PCSK_PC7_1 | 125 | 131 | PF00082 | 0.373 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.485 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.433 |
DEG_SPOP_SBC_1 | 78 | 82 | PF00917 | 0.463 |
DOC_CYCLIN_RxL_1 | 189 | 199 | PF00134 | 0.609 |
DOC_CYCLIN_yCln2_LP_2 | 119 | 122 | PF00134 | 0.469 |
DOC_PP2B_LxvP_1 | 119 | 122 | PF13499 | 0.469 |
DOC_PP2B_LxvP_1 | 194 | 197 | PF13499 | 0.647 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.528 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.663 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.460 |
LIG_14-3-3_CanoR_1 | 37 | 44 | PF00244 | 0.439 |
LIG_Actin_WH2_2 | 112 | 127 | PF00022 | 0.479 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.582 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.496 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.512 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.391 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.622 |
LIG_FHA_1 | 98 | 104 | PF00498 | 0.439 |
LIG_IRF3_LxIS_1 | 18 | 24 | PF10401 | 0.459 |
LIG_LIR_Apic_2 | 51 | 57 | PF02991 | 0.480 |
LIG_LIR_Apic_2 | 69 | 73 | PF02991 | 0.471 |
LIG_LIR_Gen_1 | 133 | 143 | PF02991 | 0.500 |
LIG_LIR_Nem_3 | 133 | 139 | PF02991 | 0.509 |
LIG_LIR_Nem_3 | 24 | 29 | PF02991 | 0.418 |
LIG_SH2_CRK | 54 | 58 | PF00017 | 0.466 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.440 |
LIG_SH2_GRB2like | 54 | 57 | PF00017 | 0.464 |
LIG_SH2_NCK_1 | 136 | 140 | PF00017 | 0.450 |
LIG_SH2_NCK_1 | 54 | 58 | PF00017 | 0.474 |
LIG_SH2_NCK_1 | 70 | 74 | PF00017 | 0.440 |
LIG_SH2_STAP1 | 136 | 140 | PF00017 | 0.477 |
LIG_SH2_STAP1 | 29 | 33 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.362 |
LIG_SH2_STAT5 | 29 | 32 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.391 |
LIG_SH3_3 | 157 | 163 | PF00018 | 0.441 |
LIG_SUMO_SIM_par_1 | 19 | 24 | PF11976 | 0.396 |
LIG_TRFH_1 | 70 | 74 | PF08558 | 0.553 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.658 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.503 |
MOD_GlcNHglycan | 165 | 169 | PF01048 | 0.662 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.623 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.654 |
MOD_GlcNHglycan | 227 | 230 | PF01048 | 0.686 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.363 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.650 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.674 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.666 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.476 |
MOD_GSK3_1 | 221 | 228 | PF00069 | 0.683 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.437 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.539 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.637 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.408 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.633 |
MOD_PKA_1 | 151 | 157 | PF00069 | 0.373 |
MOD_PKA_1 | 221 | 227 | PF00069 | 0.656 |
MOD_PKA_2 | 107 | 113 | PF00069 | 0.456 |
MOD_PKA_2 | 151 | 157 | PF00069 | 0.544 |
MOD_PKA_2 | 215 | 221 | PF00069 | 0.629 |
MOD_PKB_1 | 212 | 220 | PF00069 | 0.570 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.447 |
TRG_DiLeu_BaLyEn_6 | 1 | 6 | PF01217 | 0.516 |
TRG_ENDOCYTIC_2 | 136 | 139 | PF00928 | 0.502 |
TRG_ER_diArg_1 | 129 | 131 | PF00400 | 0.373 |
TRG_ER_diArg_1 | 211 | 214 | PF00400 | 0.529 |
TRG_NLS_MonoExtC_3 | 211 | 216 | PF00514 | 0.490 |
TRG_NLS_MonoExtN_4 | 212 | 217 | PF00514 | 0.532 |
TRG_Pf-PMV_PEXEL_1 | 37 | 41 | PF00026 | 0.433 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I303 | Leptomonas seymouri | 64% | 100% |
A0A0S4JSH4 | Bodo saltans | 29% | 100% |
A0A1X0NZI8 | Trypanosomatidae | 46% | 91% |
A0A3R7P4N9 | Trypanosoma rangeli | 44% | 98% |
A0A3S7WZA1 | Leishmania donovani | 85% | 100% |
A4I1P1 | Leishmania infantum | 85% | 100% |
C9ZK90 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9AXS5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4Q9P6 | Leishmania major | 82% | 100% |